Kubota Vision Announces Collaboration Agreement With Joslin Diabetes Center

By Staff
Tuesday, October 4, 2022 12:15 AM SEATTLE—Kubota Vision, a clinical-stage specialty ophthalmology company and a wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., announced last week that the company and Joslin Diabetes Center have entered into a material transfer and collaboration agreement for Kubota's Patient Based Ophthalmology Suite (PBOS), in-home optical coherence tomography (OCT*1) device. Joslin Diabetes Center is conducting two clinical studies to evaluate the ability of PBOS to identify cases of diabetic macular edema that may need treatment compared to a commercially-available OCT device.

ViaLase Founder and CEO, Tibor Juhasz, PhD, Honored for Helping Develop Bladeless LASIK

By Staff
Friday, September 30, 2022 12:18 AM ALISA VIEJO, Calif.— Tibor Juhasz, PhD, founder and CEO of ViaLase, Inc., was among five researchers who received the 2022 Golden Goose Award for scientific breakthroughs leading to the development of bladeless LASIK, an innovation that revolutionized refractive surgery.

Visus Therapeutics Expands Ophthalmic Drug Development Portfolio With Acquisition of ViewPoint Therapeutics’ Assets

By Staff
Thursday, September 29, 2022 12:18 AM SEATTLE, Wash.—Visus Therapeutics, a clinical stage biopharmaceutical company focused on developing multi-targeted treatments for the eye, yesterday announced it has expanded its pipeline via the acquisition of all patents and other assets of ViewPoint Therapeutics. Terms of the transaction were not disclosed. Founded in 2014, ViewPoint discovered and developed alpha-crystallin aggregation inhibitors as investigational non-surgical treatments to correct protein misfolding in the lens. Protein misfolding reduces lens elasticity and clarity leading to presbyopia and cataract, the leading causes of visual disability worldwide. Alpha-crystallin aggregation inhibitors are intended to restore elasticity and lens clarity, potentially reversing presbyopia and cataracts without the need for surgery.

National Center for Children’s Vision and Eye Health at Prevent Blindness Names Dr. Donny W. Suh as Recipient of the Bonnie Strickland Champion for Children’s Vision Award

By Staff
Thursday, September 29, 2022 12:15 AM CHICAGO—The National Center for Children’s Vision and Eye Health at Prevent Blindness (NCCVEH) has announced the recipient of the eighth annual “Bonnie Strickland Champion for Children’s Vision Award” as Donny W. Suh, MD, FAAP, MBA, FACS, chief of Pediatric Ophthalmology and Strabismus, and professor, Department of Ophthalmology and Visual Science, Gavin Herbert Eye Institute, University of California, Irvine. The award will be formally presented at the NCCVEH Annual Meeting, to be held virtually, on Friday, Oct. 14, 2022.

Santen and UBE Receive FDA Approval for Glaucoma Eye Drop

By Staff
Wednesday, September 28, 2022 12:15 AM EMERYVILLE, Calif. & UBE, Japan—Santen Inc., the U.S. subsidiary of Santen Pharmaceutical Co., Ltd. (Santen), and UBE Corporation (UBE) announced on Monday that the U.S. Food and Drug Administration (FDA) has approved OMLONTI (omidenepag isopropyl ophthalmic solution) 0.002% eye drops for the reduction of elevated intraocular pressure (IOP) in patients with primary open-angle glaucoma or ocular hypertension.

LASIK Is More Cost Effective Than Some Other Forms of Vision Correction, a New Study Shows

By Staff
Friday, September 23, 2022 12:24 AM NEW YORK—U.S. consumers who require vision correction pay about $500 annually for eyeglasses, contact lenses, eye exams and insurance, compared with about $100 for those who have had LASIK surgery, according to a new study. The study, conducted by a consortium of ophthalmologists and optometrists known as MyVision.org, pointed out although glasses and contacts are game changers for people with “bad vision,” the annual costs of an eye exam, new eyeglass lenses, a year’s supply of contacts, and prescription sunglasses can add up to a considerable amount of money over the course of a person’s lifetime.

Prism Vision Group Expands DC Metro Area Footprint With Mitchell & Morin Eye Institute Affiliation

By Staff
Thursday, September 22, 2022 12:24 AM NEW PROVIDENCE, N.J.—Prism Vision Group (PVG) announced the addition of the Mitchell & Morin Eye Institute (MMEI) to its platform. Terms of the agreement were not announced.

Eye Health America Acquires Stake in West Georgia Eye Care Center

By Staff
Saturday, September 17, 2022 12:21 AM COLUMBUS, Ga.—Eye Health America (EHA) has acquired a stake in West Georgia Eye Care Center, the largest multi-specialty ophthalmic practice in Columbus, Georgia. This is EHA’s second partnership in Georgia, and 22nd overall. Details of the transaction were not disclosed.

EyeSouth Partners Enters North Carolina With Raleigh Ophthalmology Affiliation

By Staff
Friday, September 9, 2022 12:24 AM ATLANTA—EyeSouth Partners has completed an affiliation with Raleigh Ophthalmology. The move represents EyeSouth’s 31st affiliation overall and first in the state of North Carolina.

New Study Shows That Many People Avoid Seeing an Eye Doctor

By Staff
Tuesday, September 6, 2022 2:58 PM A new study by My Vision.org is shedding light on Americans’ tendency to avoid the doctor. Although the majority do their best to stay atop their annual physicals, the nationwide survey of more than 1,050 people found many are avoiding specialists like the eye doctor. While 20 percent have gone to the eye doctor this year, 38 percent haven’t been to the eye doctor since 2020 or earlier.

Bausch + Lomb Named Exclusive Global Distributor of Alfa Instruments Intraocular Dyes

By Staff
Friday, September 2, 2022 12:18 AM VAUGHAN, Ontario and CASORIA, Italy—Bausch + Lomb Corp. and Alfa Instruments s.r.l., an Italian ophthalmic medical device company, have entered into an exclusive distribution agreement under which Bausch + Lomb will distribute and commercialize Alfa Instruments' line of surgical intraocular dyes, Vitreocare.

Second Sight Completes Merger With Nano Precision Medical, Changes Name to Vivani Medical

By Staff
Thursday, September 1, 2022 12:21 AM LOS ANGELES—Second Sight Medical Products, a leading developer of implantable visual prosthetics, announced Wednesday the completion of its merger with Nano Precision Medical.